
HHS changes how six unapproved peptides can be compounded
On Oct 28, HHS said it won't take action against licensed pharmacies and physicians that compound six unapproved peptides, including BPC-157 and TB-500, if strict conditions are met. It is not FDA approval, and the policy is temporary.


